Cramer's lightning round: Buy Regeneron, it's not getting the credit it deserves
Regeneron (REGN): "Buy, buy, buy! That company, I think, is doing great things and not getting the credit for it. [CEO] Len Schleifer's doing remarkable things in a lot of different categories." T-Mobile (TMUS): "[CEO] John Legere made an acquisition, and frankly, I'm puzzled by it. I like T-Mobile. I did not understand this video acquisition. John, come on this show and explain it to us." Electronic Arts (EA): "I like EA, but frankly, I think Take-Two (TTWO) is better and Activision Blizzard (ATVI), an ActionAlertsPlus.com club name, got a big upgrade the other day from Goldman. You should read that report. It's very positive." Acorda Therapeutics (ACOR): "No, no, no. It may not be working. When we've got high-quality situations like a Bristol-Myers (BMY), like a Merck (MRK), like a Pfizer (PFE) or like an Eli Lilly (LLY), we're going to go for those right now." Owens Corning (OC): "I'm torn here. Why? Because we had [CEO] Mike Thaman on the other day and boy, was the story great. That said, the stock's been up in a straight line, up 66 percent. We're going to wait for more of a pullback. That's too aggressive." Watch the full lightning round here: Questions for Cramer? Call Cramer: 1-800-743-CNBC Want to take a deep dive into Cramer's world? Hit him up! Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com
More From CNBC
